+91-9896593699

DRDEEPAKSHUKLA https://www.cancerinfo.in
Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

919896539256

Question- Is it possible to cure CML (CHRONIC MYELOID LEUKEMIA) one of the types of blood cancer with tablets (bcr-abl kinase inhibitor) eg imatinib, nilotinib or dasatinib?Answer- We don’t know the answer yet, but studies are now looking for stoppi

CML (chronic myeloid leukemia) is a cancer that affects bone marrow and blood.The diagnosis of CML is confirmed by presence of Philadelphia chromosome on cytogenetics or FISH or by detecting bcr-abl by PCR.It has 3 phases chronic, accelerated and b

Soon in india 2 different CDK 4/6 inhibitors will be available thus widening treatment options for hormone positive metastatic breast cancer.CDK 4/6 inhibitors are new class of drugs recently approved for metastatic hormone positive breast cancer

DIET IN PATIENTS ON CHEMOTHERAPY:Patient suffering from cancer suffer from change or loss of taste, decreased appetite. These symptoms are aggravated by presence of vomiting, constipation and diarrhea. The factors leading to these are multifactorial

ERA OF PERSONALISED MEDICINE IN METASTATIC ADENOCARCINOMA LUNG:Stage IV adenocarcinoma is not a single disease. Different molecular subtypes of NSCLC have been identified and the treatment approach is different for each subtype.The different mole

Now long term survival is possible in some stage IV solid cancers with the use of targeted, hormonal, chemotherapy drugs. The list includes:1) Stage IV hormone receptor positive metastatic breast cancer.2) Stage IV her2 nu positive metastatic breas

Maintenance with PARP inhibitor is the way forward in ovarian cancer:Median PFS in platinum sensitive relapse carcinoma ovary is approximately 10 months.20% of high grade serous carcinoma ovary have somatic or germline mutation in BRCA gene.Sin

IMMUNOTHERAPY IN LUNG CANCER- THE FUTURE OF CANCER CARE.Any cancer and lung cancer in particular creates a highly immunosuppressive environment locally i.e. our bodies immune cells are unable to recognize cancer cells.This is made possible by exp

services